Join a community of interest
Standards and specifications to electronically share health information consistently, safely and reliably
Support for digital health implementations
Resources and enablers to accelerate clinical interoperability
What's going on in clinical interoperability and digital health
What this site is about, future plans and how to reach us
Share this page:
Welcome,
Guest
|
|
Thank you for the great notes and conversation. I certainly learned a lot and I look forward to being a part of this work and seeing it implemented.
Andrea |
The administrator has disabled public write access.
|
|
Good morning folks. January 14th meeting notes are posted below and the document is available at the following link:
https://infocentral.infoway-inforoute.ca/en/resources/docs/sex-gender/sex-gender-meetings Sex and Gender Working Group January 14, 2020 Via Teleconference Agenda: 1 Welcome 2 Presentation – Sex and Gender Definitions 3 Group Discussion 4 Other Items 5 Adjournment 6 Action Items Participants: Francis Lau Marcy Antonio Kiffer Card Kelly Davison Andrea MacLean Dan Simic Finnie Flores Sisira De Sliva Robin Laird Adriana Moryski Gillian Kerr Dorell Metcalf Marcy Antonio Nathan Lachowski Andrea Mah Mukesh Kasyap Harshani Debere Prossolatos Hanine JM Joe Walsh Karen Luyendyk Abdullah Khan Aaron Devor Shelley Weslosky Mary Byrnes Beth Clarke Katie Brysk Keltie Jamieson Roz Queen Lisa Mackenzie Fariba Behzadi Lindsay McNeil Marie Train Lorraine Grieves Lisa Mroske Notes: 1. Welcome Roundtable introduction. 2. Presentation – Review of Sex-Gender Definitions Francis provided a detailed review of existing definitions in Canada, the U.S. and internationally; based in part environmental scan conducted by Infoway. Definitions are evolving. 3. Group Discussion Sex assigned at birth and sex at birth are the same thing. Gender identification and lived gender are different concepts, and someone may not feel safe to outwardly live or express their gender ID. Pronouns are a key issue; are incredibly important. In terms of recorded gender – Ontario Human Rights legislation states that a person does not have their personal ID changed in order to be respected and accepted. Sex for clinical use is context-dependent. Chromosomal sex and sex at birth also have variation. Hormonal status can be an issue. Clinical markers and lab reference ranges can change based on this data leading to what may be interpreted as abnormal results (when they are not abnormal). Some people do not even discover that they have a chromosomal sex different than what they expected until later in life. Language becomes very important in providing affirmative care. Organ status: rather than talking about a “female reproductive system,” using language like “having a uterus” is more appropriate. Terms like “hermaphrodite” are offensive and need be retired (i.e. DICOM). Being intersex is very different than being trans; couching this diversity in a term like “D” does not support the clinical cases for diverse discrete data elements reflecting diversity, and impacts all systems. Capturing specific data about diversity is very important. There is currently a lack of detailed data – this is a BIG problem. Sexual orientation may not be as prudent to this discussion as is not as important as sex and gender. Accurate gender pronouns are important for providing care. Need to develop ways to understand gender in the context of statistical analysis, data aggregation and service provision as different services use different terms. Terminology/definitions develop/change rapidly. Specifications ought to account for this change. Asking for tools to support data aggregation depending on sample size, like ICD. American/Canadian interaction around vendors. ONC ISA/SNOMED CT is used in US – international or an extension? Francis thinks a mix and will follow up. Female to male and male to female terms should not be used for gender identity. HL7 Gender Harmony project is close to the mark. Look to their work for accurate information. “Preferred pronoun” should just be personal pronoun or pronoun. “D” for gender diversity is not appropriate. Should be trans, non-binary, etc. Sex a birth – problematic for people who are intersex who may not discover that until they are older and trying to reproduce. 1% of people are born intersex. Need to consult with intersex community. Term “indeterminate” may be inappropriate. Need to consider that this language will change over time and need to think about how the ontologie(s) will adapt. 4. Other Items 5. Action items • Francis to look into SNOMED CT version for Sex/Gender used by the U.S. ONC. • Presentations and notes to be posted to the Canada Health Infoway discussion forum. • Next meeting is February 11, 2020. • Call for agenda items will be sent about a week before. |
The administrator has disabled public write access.
|
|
Many thanks to those folks who were able to attend today's meeting. I have posted both the general slide deck and the content that Dr. Francis Lau presented. The meeting slide deck is in the resources section: https://infocentral.infoway-inforoute.ca/en/resources/docs/sex-gender/sex-gender-meetings. Dr. Lau's presentation has been posted in the presentations folder: https://infocentral.infoway-inforoute.ca/en/resources/docs/sex-gender/sex-gender-presentations. Notes will be posted shortly.
|
Last Edit: 5 years 5 months ago by mastertaj. Reason: Update
The administrator has disabled public write access.
|
|
Good morning folks. A gentle reminder about our Sex-Gender Working Group Meeting tomorrow.
Agenda: 1. Welcome 2. Presentation -Review of sex-gender definitions by F. Lau* 3. Group discussion 4. Other items 5. Adjournment Please refer to Dr. Lau's working draft on review of sex-gender definitions Review of Sex-Gender Definitions for Canadian FHIR Core Profiles posted last week. Connection info: Tuesday, January 14, 2020, 12:00pm - 01:00pm ET Join Zoom Meeting https://infoway-inforoute.zoom.us/j/542316630 Meeting ID: 542 316 630 One tap mobile +16475580588,,542316630# Canada 8557038985,,542316630# Canada Toll-free Dial by your location +1 647 558 0588 Canada 855 703 8985 Canada Toll-free Meeting ID: 542 316 630 Find your local number: https://infoway-inforoute.zoom.us/u/afHtezQU6 Join by SIP This email address is being protected from spambots. You need JavaScript enabled to view it. Join by H.323 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India) 213.19.144.110 (EMEA) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan) Meeting ID: 542 316 630 Location : https://infoway-inforoute.zoom.us/j/542316630 Contact : Francis Lau |
The administrator has disabled public write access.
|
|
Tentative Agenda for Jan 14 WG meeting
1. Welcome 2. Presentation -Review of sex-gender definitions by F. Lau* 3. Group discussion 4. Other items 5. Adjournment *see attached working draft on review of sex-gender definitions Review of Sex-Gender Definitions for Canadian FHIR Core Profiles Connection info ... Tuesday, January 14, 2020, 12:00pm - 01:00pm ET by Francis Lau Infoway Sex-Gender Working Group Monthly Meeting Join Zoom Meeting https://infoway-inforoute.zoom.us/j/542316630 Meeting ID: 542 316 630 One tap mobile +16475580588,,542316630# Canada 8557038985,,542316630# Canada Toll-free Dial by your location +1 647 558 0588 Canada 855 703 8985 Canada Toll-free Meeting ID: 542 316 630 Find your local number: https://infoway-inforoute.zoom.us/u/afHtezQU6 Join by SIP This email address is being protected from spambots. You need JavaScript enabled to view it. Join by H.323 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India) 213.19.144.110 (EMEA) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan) Meeting ID: 542 316 630 Location : https://infoway-inforoute.zoom.us/j/542316630 Contact : Francis Lau |
The administrator has disabled public write access.
|
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.